Despite the clinical benefits of moderate glycemic control in the perioperative setting, insulin use in patients without diabetes was associated with worse clinical outcomes compared to patients (both with and without diabetes) who did not receive insulin in a risk-adjusted model. This evidence concerns the gene INS and diabetes mellitus.